EDGAR Filing Documents for 0000950123-09-034517

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0000950123-09-034517

Filing Date

2009-08-13

Accepted

2009-08-13 13:24:24

Documents

Period of Report

2009-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	c89287e10vq.htm	10-Q	575584
2	EXHIBIT 10.2	c89287exv10w2.htm	EX-10.2	48453
3	EXHIBIT 10.3	c89287exv10w3.htm	EX-10.3	49447
4	EXHIBIT 31.1	c89287exv31w1.htm	EX-31.1	5811
5	EXHIBIT 31.2	c89287exv31w2.htm	EX-31.2	5874
6	EXHIBIT 32.1	c89287exv32w1.htm	EX-32.1	2622
7	EXHIBIT 32.2	c89287exv32w2.htm	EX-32.2	2688
8	GRAPHIC	c89287c8928701.gif	GRAPHIC	4925
9	GRAPHIC	c89287c8928702.gif	GRAPHIC	3693
	Complete submission text file	0000950123-09-034517.txt		704203

Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922

Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330

Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)